International conference on harmonization - Good clinical practices update
被引:6
作者:
Barton, BL
论文数: 0引用数: 0
h-index: 0
机构:
US FDA, Ctr Drug Evaluat & Res, OC, DSI,CIB HRD 344, Rockville, MD 20855 USAUS FDA, Ctr Drug Evaluat & Res, OC, DSI,CIB HRD 344, Rockville, MD 20855 USA
Barton, BL
[1
]
机构:
[1] US FDA, Ctr Drug Evaluat & Res, OC, DSI,CIB HRD 344, Rockville, MD 20855 USA
来源:
DRUG INFORMATION JOURNAL
|
1998年
/
32卷
/
04期
关键词:
International Conference on Harmonization;
Good Clinical Practices;
Food and Drug Administration;
D O I:
10.1177/009286159803200434
中图分类号:
R19 [保健组织与事业(卫生事业管理)];
学科分类号:
摘要:
This paper presents an introduction to the "International Conference on Harmonization Good Clinical Practices Consolidated Guideline" for professionals who are already familiar with Food and Drug Administration (FDA) clinical trial standards. A brief background on the International Conference on Harmonization (ICH) is provided ICH-GCP is then compared to FDA standards. ICH guidelines are well supported by industry and FDA. As a result of ICH, regulatory requirements are becoming clearer and more harmonized the quality of clinical studies is improving, and the acceptance of foreign data is increasing within the ICH regions. Harmonization of the format and content of marketing applications, which is anticipated to be completed in the next few years, will bring more benefits.